Are there specific translational challenges in regenerative medicine? Lessons from other fields. Regenera7ve Medicine, pp.885-895, 2015. ,
Uncertainty and innovation: Understanding the role of cell-based manufacturing facilities in shaping regulatory and commercialization environments, Applied & Translational Genomics, vol.11, pp.27-39, 2016. ,
DOI : 10.1016/j.atg.2016.11.001
The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products First published online 17 doi: 10.1111/bjh.14384 ? A. Mahalatchimy, Reimbursement of cell-based regenerative therapy in the UK and France The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics, British Journal of Haematology Medical Law Review Regenerative Medicine, vol.176, issue.12 6, pp.9-15, 2016. ,
Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic, Regenerative Medicine, vol.22, issue.1, pp.853-864, 2017. ,
DOI : 10.1080/23299460.2016.1259929